Key Insights

Highlights

Treatment Research

1 treatments under study, led by Implantable Micro Drug Delivery Microdevice Imd

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 50/100

Termination Rate

0.0%

0 terminated out of 1 trials

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 0 completed with results

Key Signals

Data Visualizations

Phase Distribution

1Total
Early P 1 (1)

Trial Status

Not Yet Recruiting1

Clinical Trials (1)

Showing 1 of 1 trials
NCT07892300Early Phase 1Not Yet Recruiting

Implantable Microdevices for in Situ Evaluation of Drug Responses in Lung Cancer

Showing all 1 trials

Research Network

Common Treatments

  • Implantable Micro Drug Delivery Microdevice Imd1

Active Sponsors

  • Oliver Jonas1

Related Conditions

  • Mesothelioma1
  • Lung Cancer1
  • Suspected Lung Cancer1

Activity Timeline